HDFC Mutual Fund
Sectoral / Thematic · Direct · Growth
NAV as of 30 Oct 2026 · Source: AMFI
HDFC Pharma and Healthcare Fund is a Sectoral / Thematic fund from HDFC Mutual Fund, with NAVs going back to October 2023. This page covers its direct plan, growth option. It manages ₹3,640 crore, the 39th largest of 246 Sectoral / Thematic funds. Its expense ratio is 1.05% a year, lower than the median of 1.15% for Sectoral / Thematic funds.
Over the last three years it returned 30.60% a year, 3rd of 137 Sectoral / Thematic funds (median 12.96%). It is 7.70 percentage points a year ahead of its benchmark, the BSE Healthcare TRI, over three years, on AMFI's figures. Its biggest fall from a peak in the last three years was 14.9%, and AMFI's riskometer rates it Very High.
Annualised (CAGR) for periods over a year, calculated from AMFI NAVs up to 30 Oct 2026. Past performance does not guarantee future returns. How we calculate returns
1 Year
+23.14%
3 Years
+30.60%
Since launch (4 Oct 2023)
+29.32%
Fund and benchmark returns as published by AMFI for 29 Oct 2026, so both sides use the same date and method. They can differ slightly from the figures above.
| Period | This fund | Benchmark | Difference |
|---|---|---|---|
| 1 Year | +22.64% | +10.81% | +11.83 pts |
| 3 Years | +30.41% | +22.71% | +7.70 pts |
| Since launch | +29.15% | +21.15% | +8.00 pts |
Measured from this fund's own daily NAVs over the last three years.
Volatility (annualised)
14.2%
How much the NAV typically swings in a year. Higher means a bumpier ride.
Worst fall from a peak
-14.9%
The biggest drop from a high to a later low. A sense of what a bad stretch has looked like.
Daily NAV since 4 Oct 2023.
These come from the fund's monthly factsheet and Scheme Information Document (SID). We don't show them yet, because we can't keep them accurate. Check them on HDFC Mutual Fund's website before you invest.
Funds next to HDFC Pharma and Healthcare Fund, in the same category, ranked by 3-year return.
SBI Mutual Fund
Sectoral / Thematic
+24.8% 3Y CAGR
HDFC Pharma and Healthcare Fund - Growth Option - Direct Plan
Research-only · No transactions